参考文献/References:
[1] Davis RL, Weintraub H, Lassar AB. Expression of a single transfected cDNA converts fibroblasts to myoblasts[J]. Cell, 1987,51(6):987-1000.
[2] Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors[J]. Cell, 2006,126(4):663-676.
[3] Zhou Q, Brown J, Kanarek A, et al. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells[J]. Nature, 2008,455(7213):627-632.
[4] Ieda M, Fu JD, Delgado-Olguin P, et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors[J]. Cell, 2010,142(3):375-386.
[5] Perrino C, Rockman HA. GATA4 and the two sides of gene expression reprogramming[J]. Circ Res, 2006,98(6):715-716.
[6] Wang L, Liu Z, Yin C, et al. Stoichiometry of Gata4, Mef2c, and Tbx5 influences the efficiency and quality of induced cardiac myocyte reprogramming[J]. Circ Res, 2015,116(2):237-244.
[7] Addis RC, Ifkovits JL, Pinto F, et al. Optimization of direct fibroblast reprogramming to cardiomyocytes using calcium activity as a functional measure of success[J]. J Mol Cell Cardiol, 2013,60:97-106.
[8] Hirai H, Katoku-Kikyo N, Keirstead SA, et al. Accelerated direct reprogramming of fibroblasts into cardiomyocyte-like cells with the MyoD transactivation domain[J]. Cardiovasc Res, 2013,100(1):105-113.
[9] Islas JF, Liu Y, Weng KC, et al. Transcription factors ETS2 and MESP1 transdifferentiate human dermal fibroblasts into cardiac progenitors[J]. Proc Natl Acad Sci U S A, 2012,109(32):13016-13021.
[10] Sadahiro T, Isomi M, Muraoka N, et al. Tbx6 induces nascent mesoderm from pluripotent stem cells and temporally controls cardiac versus somite lineage diversification[J]. Cell Stem Cell, 2018,23(3):382-395.
[11] Ivey KN, Muth A, Arnold J, et al. MicroRNA regulation of cell lineages in mouse and human embryonic stem cells[J]. Cell Stem Cell, 2008,2(3):219-229.
[12] Song K, Nam YJ, Luo X, et al. Heart repair by reprogramming non-myocytes with cardiac transcription factors[J]. Nature, 2012,485(7400):599-604.
[13] Hirai H, Katoku-Kikyo N, Keirstead SA, et al. Accelerated direct reprogramming of fibroblasts into cardiomyocyte-like cells with the MyoD transactivation domain[J]. Cardiovasc Res, 2013,100(1):105-113.
[14] Addis RC, Ifkovits JL, Pinto F, et al. Optimization of direct fibroblast reprogramming to cardiomyocytes using calcium activity as a functional measure of success[J]. J Mol Cell Cardiol, 2013,60:97-106.
[15] Muraoka N, Yamakawa H, Miyamoto K, et al. MiR-133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures[J]. EMBO J, 2014,33(14):1565-1581.
[16] He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation[J]. Nat Rev Genet, 2004,5(7):522-531.
[17] Jayawardena TM, Finch EA, Zhang L, et al. MicroRNA induced cardiac reprogramming in vivo: evidence for mature cardiac myocytes and improved cardiac function[J]. Circ Res, 2015,116(3):418-424.
[18] Eulalio A, Mano M, Dal Ferro M, et al. Functional screening identifies miRNAs inducing cardiac regeneration[J]. Nature, 2012,492(7429):376-381.
[19] Singh VP, Mathison M, Patel V, et al. MiR-590 promotes transdifferentiation of porcine and human fibroblasts toward a cardiomyocyte-like fate by directly repressing specificity protein 1[J]. J Am Heart Assoc, 2016,5(11):e003922.
[20] Zhao Y, Londono P, Cao Y, et al. High-efficiency reprogramming of fibroblasts into cardiomyocytes requires suppression of pro-fibrotic signalling[J]. Nat Commun, 2015,6:8243.
[21] Abad M, Hashimoto H, Zhou H, et al. Notch Inhibition Enhances Cardiac Reprogramming by Increasing MEF2C Transcriptional Activity[J]. Stem Cell Reports, 2017,8(3):548-560.
[22] Jayawardena TM, Egemnazarov B, Finch EA, et al. MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes[J]. Circ Res, 2012,110(11):1465-1473.
[23] Lalit PA, Salick MR, Nelson DO, et al. Lineage reprogramming of fibroblasts into proliferative induced cardiac progenitor cells by defined factors[J]. Cell Stem Cell, 2016,18(3):354-367.
[24] Karakikes I, Senyei GD, Hansen J, et al. Small molecule-mediated directed differentiation of human embryonic stem cells toward ventricular cardiomyocytes[J]. Stem Cells Transl Med, 2014,3(1):18-31.
[25] Wang H, Cao N, Spencer CI, et al. Small molecules enable cardiac reprogramming of mouse fibroblasts with a single factor, Oct4[J]. Cell Rep, 2014,6(5):951-960.
[26] Park G, Yoon BS, Kim YS, et al. Conversion of mouse fibroblasts into cardiomyocyte-like cells using small molecule treatments[J]. Biomaterials, 2015,54:201-212.
[27] Fu Y, Huang C, Xu X, et al. Direct reprogramming of mouse fibroblasts into cardiomyocytes with chemical cocktails[J]. Cell Res, 2015,25(9):1013-1024.
[28] Cao N, Huang Y, Zheng J, et al. Conversion of human fibroblasts into functional cardiomyocytes by small molecules[J]. Science, 2016,352(6290):1216-1220.
[29] Panciera T, Azzolin L, Fujimura A, et al. Induction of Expandable Tissue-Specific Stem/Progenitor Cells through Transient Expression of YAP/TAZ[J]. Cell Stem Cell, 2016,19(6):725-737.
[30] Liu Z, Chen O, Zheng M, et al. Re-patterning of H3K27me3, H3K4me3 and DNA methylation during fibroblast conversion into induced cardiomyocytes[J]. Stem Cell Res, 2016,16(2):507-518.
[31] Dal-Pra S, Hodgkinson C P, Mirotsou M, et al. Demethylation of H3K27 Is Essential for the Induction of Direct Cardiac Reprogramming by miR Combo[J]. Circ Res, 2017,120(9):1403-1413.
[32] Zhou Y, Wang L, Vaseghi HR, et al. Bmi1 is a key epigenetic barrier to direct cardiac reprogramming[J]. Cell Stem Cell, 2016,18(3):382-395.
[33] Fu JD, Stone NR, Liu L, et al. Direct reprogramming of human fibroblasts toward a cardiomyocyte-like state[J]. Stem Cell Reports, 2013,1(3):235-247.
[34] Muraoka N, Nara K, Tamura F, et al. Role of cyclooxygenase-2-mediated prostaglandin E2-prostaglandin E receptor 4 signaling in cardiac reprogramming[J]. Nat Commun, 2019,10(1):674.
[35] Qian L, Huang Y, Spencer CI, et al. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes[J]. Nature, 2012,485(7400):593-598.
[36] Merten OWGB. Viral vectors for gene therapy and gene modification approaches[J]. Biochem Engineering J, 2016,108:98-115.
[37] Miyamoto K, Akiyama M, Tamura F, et al. Direct in vivo reprogramming with sendai virus vectors improves cardiac function after myocardial infarction[J]. Cell Stem Cell, 2018,22(1):91-103.
[38] Warren L, Manos PD, Ahfeldt T, et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA[J]. Cell Stem Cell, 2010,7(5):618-630.
[39] Chang Y, Lee E, Kim J, et al. Efficient in vivo direct conversion of fibroblasts into cardiomyocytes using a nanoparticle-based gene carrier[J]. Biomaterials, 2019,192:500-509.